Advaxis

Advaxis

Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases. Learn more

Launch date
Employees
Market cap
AUD1.3m
Enterprise valuation
AUD7m (Public information from Sep 2024)
Princeton New Jersey (HQ)
Authorizing premium user...